Search Results - "VASE, Julie M"

Follicular Lymphoma in the United States: First Report of the National LymphoCare Study by FRIEDBERG, Jonathan W, TAYLOR, Michael D, ZELENETZ, Andrew D, LINK, Brian K, CERHAN, James R, FLOWERS, Christopher R, DILLON, Hildy, FARBER, Charles M, ROGERS, Eric S, HAINSWORTH, John D, WONG, Elaine K, VOSE, Julie M

“…Optimal therapy of follicular lymphoma (FL) is not defined. We analyzed a large prospective cohort study to identify current demographics and patterns of care…”
Get full text

BCL2 Expression Is a Prognostic Marker for the Activated B-Cell–Like Type of Diffuse Large B-Cell Lymphoma by IQBAL, Javeed, NEPPALLI, Vishala T, GASCOYNE, Randy D, CAMPO, Elias, OTT, German, MÜLLER-HERMELINK, H. Konrad, DELABIE, Jan, JAFFE, Elaine S, GROGAN, Thomas M, CONNORS, Joseph M, VASE, Julie M, ARMITAGE, James O, WRIGHT, George, STAUDT, Louis M, CHAN, Wing C, DAVE, Bhavana J, HORSMAN, Douglas E, ROSENWALD, Andreas, LYNCH, James, HANS, Christine P, WEISENBURGER, Dennis D, GREINER, Timothy C

“…The role of BCL2 as a predictor of survival in diffuse large B-cell lymphoma (DLBCL) is controversial. DLBCL is heterogeneous, and the expression of BCL2 is…”
Get full text

Phase I/II Study of Galiximab, an Anti-CD80 Antibody, for Relapsed or Refractory Follicular Lymphoma by CZUCZMAN, Myron S, THALL, Aron, SWEETENHAM, John, ALKUZWENY, Baha, FINUCANE, Deborah M, LEIGH, Bryan R, WITZIG, Thomas E, VASE, Julie M, YOUNES, Anas, EMMANOUILIDES, Christos, MILLER, Thomas P, MOORE, Joseph O, LEONARD, John P, GORDON, Leo I

“…This multicenter, dose-escalation study evaluates the safety, pharmacokinetics, and efficacy of galiximab (anti-CD80 monoclonal antibody) in patients with…”
Get full text

Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma by Devetten, Marcel P, Hari, Parameswaran N, Carreras, Jeanette, Logan, Brent R, van Besien, Koen, Bredeson, Christopher N, Freytes, César O, Gale, Robert Peter, Gibson, John, Giralt, Sergio A, Goldstein, Steven C, Gupta, Vikas, Marks, David I, Maziarz, Richard T, Vose, Julie M, Lazarus, Hillard M, Anderlini, Paolo

“…Abstract Myeloablative allogeneic hematopoietic cell transplantation (HCT) may cure patients with relapsed or refractory Hodgkin lymphoma (HL), but is…”
Get full text